In the context of m6A modification, elevated levels of METTL3 expression correlate with unfavorable prognosis, increased tumor malignancy, and reduced overall survival (OS) (Yu and Yang, 2024; Zhang Z. et al., 2023; Su et al., 2022b). Here, METTL3 is linked to neoplasm.